{
    "nctId": "NCT04881604",
    "briefTitle": "Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema",
    "officialTitle": "Compressive Therapy by Adjustable Compression Garment (Ready Wrap\u00ae) in Breast Cancer-related Lymphedema: Randomized Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Related Lymphedema, Lymphedema, Secondary, Lymphedema of Upper Arm, Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 72,
    "primaryOutcomeMeasure": "Arm volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women\n\n1. Age over 18 years\n2. Undergo surgical treatment for breast cancer\n3. Diagnosed with lymphedema in the upper limb stabilized for a period \u22656 months\n4. Indicated the second phase of compressive therapy / treatment of lymphedema\n\nExclusion Criteria:\n\n1. Women with:\n\n1. Bilateral lymphedema;\n2. Lymphedema since the preoperative period;\n3. Presence of phlogistic signs in the limb with lymphedema;\n4. Treatment of lymphedema (phase 1) in the last three months;\n5. Previous history of allergic reaction to the material used for compressive therapy;\n6. Active regional or remote disease;\n7. In chemotherapy or radiation therapy;\n8. Functional changes in the upper limbs prior to the diagnosis of breast cancer;\n9. Heart disease and decompensated systemic arterial hypertension; psychiatric, mental, neurological disorders or cognitive deficits that make it impossible to answer the questionnaires.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}